Your browser doesn't support javascript.
loading
Physicochemical and microbiological stability study of two new preservative-free methylprednisolone eye drops. / Estudio de estabilidad fisicoquímica y microbiológica de 2 nuevos colirios de metilprednisolona sin conservantes.
Merino-Bohórquez, Vicente; Berisa-Prado, Silvia; Delgado-Valverde, Mercedes; Tirado-Pérez, María José; García-Palomo, Marta; Alonso-Herreros, José María; Cañete-Ramírez, Carme; Dávila-Pousa, María Del.
Afiliación
  • Merino-Bohórquez V; Servicio de Farmacia, Hospital Universitario Virgen Macarena, Sevilla, España; Departamento de Farmacología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, España. Electronic address: vicente.merino.sspa@juntadeandalucia.es.
  • Berisa-Prado S; Servicio de Farmacia, Clínica Universitaria de Navarra, Navarra, España.
  • Delgado-Valverde M; Servicio de Microbiología Clínica, Hospital Universitario Virgen Macarena, Sevilla, España.
  • Tirado-Pérez MJ; Servicio de Farmacia, Hospital Universitario Virgen Macarena, Sevilla, España.
  • García-Palomo M; Servicio de Farmacia, Hospital Universitario de Toledo, Toledo, España.
  • Alonso-Herreros JM; Servicio de Farmacia, Hospital General Universitario de Los Arcos del Mar Menor, Murcia, España.
  • Cañete-Ramírez C; Servicio de Farmacia, Hospital Universitario Vall´d Hebron, Barcelona, España.
  • Dávila-Pousa MD; Servicio de Farmacia, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, España.
Farm Hosp ; 2024 Apr 02.
Article en En, Es | MEDLINE | ID: mdl-38570209
ABSTRACT

OBJECTIVE:

To study the physicochemical and microbiological stability over 90 days of two preservative-free methylprednisolone sodium succinate (MTPSS) 1 mg/ml and 10 mg/ml eye drops for use in ocular pathologies such as Sjögren's syndrome and dry eye syndrome.

METHOD:

The two eye drops were prepared from injectable MTPSS (Solu-moderin® and Urbason®), water for injection and normal saline solution. In accordance with ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use) guidelines, they were then stored in triplicate under refrigerated conditions (5 ±3 °C), at room temperature (25 ± 2 °C), and at 40 °C (±2 °C). In accordance with the USP (United States Pharmacopeia), physicochemical controls of the active ingredient content were carried out by HPLC-UV (High Performance Liquid Chromatography with Ultraviolet detection), together with controls of pH, osmolality, and visual examination. Microbiological sterility was also tested under refrigerated conditions up to 30 days in open containers and up to 90 days in closed ones.

RESULTS:

The eye drops stored at 5 °C were the most stable; in the 1 mg/ml eye drops, degradation of the drug fell below 90% from day 21, and in the 10 mg/ml eye drops, from day 42. pH change did not vary by ≥1 unit in formulations stored at 5 °C, unlike the other formulations. Changes in osmolality did not exceed 5% on day 90 in any storage conditions. Samples of non refrigerate eye drops at 10 mg/ml, presented a white precipitate from day 14 and 28 respectively. Non-refrigerated 1 mg/ml eye drops presented suspended particles on day 90. There were no color changes. Microbiological analysis showed that sterility was maintained for over 90 days in the closed containers, although microbial contamination was detected from day 21 in the open containers.

CONCLUSIONS:

1 mg/ml MTPSS eye drops show physicochemical and microbiological stability for 21 days under refrigeration, compared to 42 days for 10 mg/ml eye drops stored under the same conditions. However, since they do not include preservatives in their composition, they should not be used for more than 7 days after opening.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En / Es Revista: Farm Hosp Asunto de la revista: FARMACIA / HOSPITAIS Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En / Es Revista: Farm Hosp Asunto de la revista: FARMACIA / HOSPITAIS Año: 2024 Tipo del documento: Article